Is Trident Texofab overvalued or undervalued?

Aug 30 2025 08:08 AM IST
share
Share Via
As of August 29, 2025, Trident Texofab is considered overvalued with a valuation grade of expensive, reflected in its high PE ratio of 133.86, EV to EBITDA of 76.80, and PEG ratio of 6.36, especially when compared to peers like PTC India at 8.35 and Lloyds Enterprises at 38.87, despite a remarkable 1-year return of 456.44%.
As of 29 August 2025, the valuation grade for Trident Texofab has moved from very expensive to expensive. The company is currently considered overvalued based on its high valuation ratios. Notable ratios include a PE ratio of 133.86, an EV to EBITDA of 76.80, and a PEG ratio of 6.36, all of which indicate a premium valuation compared to typical industry standards.

In comparison to peers, Trident Texofab's PE ratio significantly exceeds that of PTC India, which is very attractive at 8.35, and Lloyds Enterprises, which is very expensive at 38.87. This stark contrast highlights the overvaluation of Trident Texofab. Additionally, the company's recent stock performance has been impressive, with a 1-year return of 456.44%, far outpacing the Sensex's decline of 2.83%, although this does not mitigate the concerns regarding its current valuation.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Trident Texofab falling/rising?
Dec 17 2025 01:14 AM IST
share
Share Via
Is Trident Texofab overvalued or undervalued?
Dec 05 2025 08:41 AM IST
share
Share Via
Is Trident Texofab technically bullish or bearish?
Dec 04 2025 08:47 AM IST
share
Share Via
How has been the historical performance of Trident Texofab?
Dec 03 2025 10:55 PM IST
share
Share Via
Is Trident Texofab overvalued or undervalued?
Nov 19 2025 08:10 AM IST
share
Share Via